In this study, we for the first time uncover the important regulatory role of circ‐CMPK1/miR‐302e/cyclin D1 ceRNA network in NSCLC, which provides promising prognostic indicators and potential therapeutic targets for NSCLC patients. This evidence concerns the gene CMPK1 and non-small cell lung carcinoma.